| | |
Elixhauser co-morbidities
|
|---|
| |
Total
|
0
|
1
|
2
|
3+
|
|---|
|
Total
|
2,323 (100)
|
1,960 (84.4)
|
223 (9.6)
|
63 (2.7)
|
77 (3.3)
|
|
FIGO stage
| | | | | |
|
0 to IB2
|
1,155 (49.7)
|
1,067 (92.4)
|
63 (5.5)
|
13 (1.1)
|
12 (1.0)*
|
|
II to IIB
|
262 (11.3)
|
207 (79.0)
|
32 (12.2)
|
11 (4.2)
|
12 (4.6)
|
|
III to IIIB
|
232 (10.0)
|
169 (72.8)
|
41 (17.7)
|
16 (6.9)
|
6 (2.6)
|
|
IVA to IVB
|
53 (2.3)
|
33 (62.3)
|
11 (20.8)
|
3 (5.7)
|
6 (11.3)
|
|
Missing
|
621 (26.7)
|
484 (77.9)
|
76 (12.2)
|
20 (3.2)
|
41 (6.6)
|
|
Ethnicity
| | | | | |
|
Other
|
1,674 (72.1)
|
1,444 (86.3)
|
141 (8.4)
|
41 (2.5)
|
48 (2.9)*
|
|
Māori
|
416 (17.9)
|
334 (80.3)
|
50 (12.0)
|
15 (3.6)
|
17 (4.1)
|
|
Pacific
|
105 (4.5)
|
71 (67.6)
|
21 (20.0)
|
3 (2.9)
|
10 (9.5)
|
|
Asian
|
128 (5.5)
|
111 (86.7)
|
11 (8.6)
|
4 (3.1)
|
2 (1.6)
|
|
NZDep2001, quintiles
| | | | | |
|
1 (Least deprived)
|
298 (12.8)
|
277 (93.0)
|
14 (4.7)
|
3 (1.0)
|
4 (1.3)**
|
|
2
|
333 (14.3)
|
283 (85.0)
|
33 (9.9)
|
8 (2.4)
|
9 (2.7)
|
|
3
|
416 (17.9)
|
350 (84.1)
|
37 (8.9)
|
12 (2.9)
|
17 (4.1)
|
|
4
|
526 (22.6)
|
432 (82.1)
|
56 (10.7)
|
19 (3.6)
|
19 (3.6)
|
|
5 (Most deprived)
|
623 (26.8)
|
510 (81.9)
|
67 (10.8)
|
21 (3.4)
|
25 (4.0)
|
|
Missing
|
127 (5.5)
|
108 (85.0)
|
16 (12.6)
|
0
|
3 (2.4)
|
|
Urban/rural residency
| | | | | |
|
Main urban
|
1,640 (70.6)
|
1,403 (85.6)
|
141 (8.6)
|
42 (2.6)
|
54 (3.3)NS
|
|
Secondary urban
|
361 (15.5)
|
288 (79.8)
|
47 (13.0)
|
13 (3.6)
|
13 (3.6)
|
|
Rural
|
196 (8.4)
|
162 (82.7)
|
19 (9.7)
|
8 (4.1)
|
7 (3.6)
|
|
Missing
|
126 (5.4)
|
107 (84.9)
|
16 (12.7)
|
0
|
3 (2.4)
|
|
Year of diagnosis
| | | | |
|
1994-1997
|
843 (36.3)
|
714 (84.7)
|
82 (9.7)
|
24 (2.9)
|
23 (2.7)NS
|
|
1998-2001
|
815 (35.1)
|
689 (84.5)
|
79 (9.7)
|
20 (2.5)
|
27 (3.3)
|
|
2002-2005
|
665 (28.6)
|
557 (83.8)
|
62 (9.3)
|
19 (2.9)
|
27 (4.1)
|
- p value based on Pearson's chi-squared
- * p = 0.0001
- ** p = 0.02
- NS: Not significant at 95%
